SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-030439
Filing Date
2024-04-04
Accepted
2024-04-04 16:31:32
Documents
102
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202964-20f_neuro.htm   iXBRL 20-F 2428335
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF ea020296401ex2-1_neuro.htm EX-2.1 58107
3 LIST OF SUBSIDIARIES OF NEUROSENSE THERAPEUTICS LTD ea020296401ex8-1_neuro.htm EX-8.1 2957
4 CERTIFICATION ea020296401ex12-1_neuro.htm EX-12.1 16313
5 CERTIFICATION ea020296401ex12-2_neuro.htm EX-12.2 11922
6 CERTIFICATION ea020296401ex13-1_neuro.htm EX-13.1 4184
7 CERTIFICATION ea020296401ex13-2_neuro.htm EX-13.2 4078
8 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea020296401ex15-1_neuro.htm EX-15.1 1952
9 CLAWBACK POLICY ea020296401ex97-1_neuro.htm EX-97.1 27551
10 GRAPHIC image_001.jpg GRAPHIC 107528
  Complete submission text file 0001213900-24-030439.txt   8444790

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE nrsn-20231231.xsd EX-101.SCH 107715
12 XBRL CALCULATION FILE nrsn-20231231_cal.xml EX-101.CAL 36806
13 XBRL DEFINITION FILE nrsn-20231231_def.xml EX-101.DEF 308767
14 XBRL LABEL FILE nrsn-20231231_lab.xml EX-101.LAB 618354
15 XBRL PRESENTATION FILE nrsn-20231231_pre.xml EX-101.PRE 322084
106 EXTRACTED XBRL INSTANCE DOCUMENT ea0202964-20f_neuro_htm.xml XML 964324
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41084 | Film No.: 24823543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)